Víctor J. Sánchez‐Arévalo Lobo

Universidad Francisco de Vitoria — Spain

Medicine · Health Sciences

17h-index1.5kcitations60works3.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pancreatic and Hepatic Oncology Research(27), Cancer, Hypoxia, and Metabolism(15), Pancreatic function and diabetes(10), RNA modifications and cancer(9), Neuroendocrine Tumor Research Advances(7)

Publications60 total

A PGLYRP1-related signaling cascade initiated by cancer stem cells influences subtype identity in pancreatic ductal adenocarcinoma
Pancreatology·2025
Deep Learning based deconvolution methods: a systematic review
2025Open Access
Targeting ELOVL6 to disrupt c-MYC driven lipid metabolism in pancreatic cancer enhances chemosensitivity
Nature Communications·2025· 10 citedOpen Access
Deep learning based deconvolution methods: A systematic review
Computational and Structural Biotechnology Journal·2025· 1 citedOpen Access
ELOVL6 as a Therapeutic Target: Disrupting c-MYC-Driven Lipid Metabolism to Enhance Chemotherapy in Pancreatic Cancer
2024Open Access
Fatty acid amide hydrolase gene inactivation induces hetero‐cellular potentiation of microglial function in the <scp>5xFAD</scp> mouse model of Alzheimer's disease
Glia·2024· 3 citedOpen Access
Pymportx: facilitating next-generation transcriptomics analysis in Python
NAR Genomics and Bioinformatics·2024Open Access
Pymportx: Facilitating Next-Generation Transcriptomics Analysis in Python
2024Open Access
The Peptidoglycan Recognition Protein 1 confers immune evasive properties on pancreatic cancer stem cells
Gut·2024· 14 citedOpen Access
pTERT C250T mutation: A potential biomarker of poor prognosis in metastatic melanoma
Heliyon·2023· 7 citedOpen Access
Supplementary Figure 5 from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
2023Open Access
Supplementary Figure 2 from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
2023Open Access
Supplementary Figure 5 from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
2023Open Access
Data from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
2023Open Access
Supplementary Figure 1 from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
2023Open Access
Supplementary Figure 3 from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
2023Open Access
Supplementary Figure 6 from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
2023Open Access
Data from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
2023Open Access
Supplementary Tables 1-5 from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
2023Open Access
Supplementary Figure 2 from Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Francisco X. Real(22), José M. Mazarico(11), Rosy Favicchio(11), William Greenhalf(11), Eithne Costello(11), Juan Carlos Lacal(11), Eric O. Aboagye(11), Enrique Carrillo-de Santa Pau(10), Miriam Marqués(10), Javier Hernández‐Losa(7), Ricardo Sánchez‐Prieto(7), Santiago Ramón y Cajal(6), Raúl Muñoz Velasco(6), Laia Richart(5), José Luis Rodríguez‐­Peralto(5), Ana García García(5), Juan Guinea Viniegra(4), Carlos Parada Cobo(4), Luis Álvarez‐Vallina(4), Enrique Carrillo de Santa Pau(4)